![Christine Ginocchio](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Christine Ginocchio is currently the Chief Medical & Scientific Officer at VedaBio, Inc. Prior to her current position, she served as the Chief Scientific & Medical Officer at Quotient Ltd.
from 2021 to 2023.
She also held the role of Senior Vice President-Global Medical Affairs at bioMérieux SA.
Postes actifs de Christine Ginocchio
Sociétés | Poste | Début |
---|
Anciens postes connus de Christine Ginocchio
Sociétés | Poste | Fin |
---|---|---|
QUOTIENT LIMITED | Directeur Technique/Scientifique/R&D | 01/09/2023 |
BIOMÉRIEUX | Directeur Technique/Scientifique/R&D | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
BIOMÉRIEUX | Health Technology |
Entreprise privées | 1 |
---|---|
Quotient Ltd.
![]() Quotient Ltd. Electronic Equipment/InstrumentsElectronic Technology Quotient Ltd. is a commercial-stage diagnostics company, which provides immunohematology products to hospitals and blood banks. Its products and services include MOSAIQ and ALBA. The firm develops, manufactures, and sells conventional reagent products to equipment manufacturers. It engages in transfusion diagnostics, which focuses on blood grouping and serological disease screening. The company was founded on January 18, 2012 and is headquartered in Eysins, Switzerland. | Electronic Technology |